MedTrace Logo

Cancer Survivor Cardiomyopathy Detection

NCT05201014 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2025-09-05

No results posted yet for this study

Summary

The purpose of this study is to improve the cardiovascular care of adult cancer survivors. The goal is to obtain the data necessary to plan and develop a nation-wide network of a screening program that can help provide cost-effective and long-term monitoring.

Conditions

Interventions

DIAGNOSTIC_TEST

NT-pro-BNP

Blood draw

DIAGNOSTIC_TEST

Electrocardiogram

electrodes are placed on certain spots and a reading obtained to measure the voltage of the heart

DIAGNOSTIC_TEST

Echocardiogram

medical imaging of the heart

Sponsors & Collaborators

  • Florida Heart Research Institute

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Joerg Herrmann, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-03
Primary Completion
2026-09-20
Completion
2026-09-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05201014 on ClinicalTrials.gov